Using a second set of GBM tumor samples (n = 20, samples frozen at –80°C), we used dual-label immunofluorescence to evaluate the expression of FOXO3 and SOX2 within the same tumor region and cell. This evidence concerns the gene FOXO3 and glioblastoma.